Literature DB >> 28751034

Current concepts on hematopoietic stem cell transplantation outcome registries; Emphases on resource requirements for new registries.

Fazal Hussain1, Naeem Chaudhri2, Feras Alfraih2, Mahmoud Aljurf2.   

Abstract

There is tremendous variability in size, scope, and resource requirements for registries depending on the number of patients and participating sites. The outcome registries are organized systems to collect uniform data using an observational study methodology. Patient registries are used to determine specified outcomes for a population for predetermined scientific, clinical, or policy purposes. Historically, outcome registries established in the development of hematopoietic stem cell transplantation (HSCT) have now evolved into myriads of locoregional and international transplant activity and outcome resources. Over time, these registries have contributed immensely in determining trends, patterns, and treatment outcomes in HSCT. There is wider variation in the goals, mission, objectives, and outcomes of the ongoing registries depending on the organizational structure. There is a growing trend toward overarching relationship of these registries to serve as complementary and interoperable resources for high potential collaborative research. In addition to capacity building, standardized, accredited, and optimally operational registries can provide unmatched and unparalleled research data that cannot be obtained otherwise. Moving forward, HSCT data collection, collation, and interpretation should be an integral part of the treatment rather than an option. Quality assurance and continuous quality improvement of the data are pivotal for credibility, measurable/quantifiable outcomes, clinically significant impact, and setting new benchmarks.
Copyright © 2017 King Faisal Specialist Hospital & Research Centre. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Challenges; Data utilization; HSCT registry; Opportunities; Outcome analysis

Mesh:

Year:  2017        PMID: 28751034     DOI: 10.1016/j.hemonc.2017.05.011

Source DB:  PubMed          Journal:  Hematol Oncol Stem Cell Ther


  1 in total

Review 1.  Artificial Intelligence Approaches in Hematopoietic Cell Transplantation: A Review of the Current Status and Future Directions

Authors:  Ibrahim N. Muhsen; Tusneem ElHassan; Shahrukh K Hashmi
Journal:  Turk J Haematol       Date:  2018-06-08       Impact factor: 1.831

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.